Literature DB >> 7588959

Rapid occurrence of thelarche and menarche induced by hydrocortisone in a teenage girl with previously untreated congenital adrenal hyperplasia.

H P Schwarz1, A Jocham, U Kuhnle.   

Abstract

UNLABELLED: A 14-year-old girl with untreated simple virilizing congenital adrenal hyperplasia presented with absent breast development. She had not had menarche. During treatment with hydrocortisone, breasts progressed from Tanner stage one to three within 6 months and menarche occurred after 10 months. However, a 1.5 cm pituitary adenoma, later described as unspecific pituitary enlargement, remained unchanged.
CONCLUSION: In a female with untreated congenital adrenal hyperplasia and an adult bone age, signs of puberty appeared very rapidly once appropriate treatment had begun. This was supposedly due to the declining androgen secretion from the adrenals and the release of their restraining action on the hypothalamic-pituitary ovarian axis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588959     DOI: 10.1007/BF02079062

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. II. The effects of cortisone on sexual and somatic development, with an hypothesis concerning the mechanism of feminization.

Authors:  L WILKINS; J F CRIGLER; S H SILVERMAN; L I GARDNER; C J MIGEON
Journal:  J Clin Endocrinol Metab       Date:  1952-03       Impact factor: 5.958

2.  Treatment of congenital adrenal hyperplasia with cortisone.

Authors:  L WILKINS; R A LEWIS; R KLEIN; L I GARDNER; J F CRIGLER; E ROSEMBERG; C J MIGEON
Journal:  J Clin Endocrinol Metab       Date:  1951-01       Impact factor: 5.958

3.  Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility.

Authors:  G J Klingensmith; S C Garcia; H W Jones; C J Migeon; R M Blizzard
Journal:  J Pediatr       Date:  1977-06       Impact factor: 4.406

4.  Plasma estrogens in childhood and puberty under physiologic and pathologic conditions.

Authors:  F Bidlingmaier; M Wagner-Barnack; O Butenandt; D Knorr
Journal:  Pediatr Res       Date:  1973-11       Impact factor: 3.756

5.  Pubertal development in Swiss girls.

Authors:  R H Largo; A Prader
Journal:  Helv Paediatr Acta       Date:  1983-08

Review 6.  The estrogenic and antiestrogenic activities of androgens in female target tissues.

Authors:  H Rochefort; M Garcia
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

7.  An acth-secreting pituitary tumour arising in a patient with congenital adrenal hyperplasia.

Authors:  P M Horrocks; S Franks; A D Hockley; E B Rolfe; S Van Noorden; D R London
Journal:  Clin Endocrinol (Oxf)       Date:  1982-11       Impact factor: 3.478

8.  True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.

Authors:  O H Pescovitz; F Comite; F Cassorla; A J Dwyer; M A Poth; M A Sperling; K Hench; A McNemar; M Skerda; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

9.  Oestrogen dynamics in adrenal venous effluents in congenital virilizing adrenal hyperplasia.

Authors:  B L Wajchenberg; J Goldman; T S Kyan; S S Achando; Y L Thomsen; S S Lima
Journal:  Clin Endocrinol (Oxf)       Date:  1980-10       Impact factor: 3.478

10.  Evaluation of the gonadotropic responsiveness of the pituitary to acute and prolonged administration of LH/FSH-releasing hormone (lhrh) in untreated patients with congenital adrenal hyperplasia.

Authors:  B L Wajchenberg; H Pinto; S S Achando; T S Kiyan; H Okada; J Goldman; R T Betti; B Liberman; I L Thomsen
Journal:  Metabolism       Date:  1981-10       Impact factor: 8.694

View more
  2 in total

1.  Outcome of congenital adrenal hyperplasia.

Authors:  U Kuhnle; M Bullinger
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

2.  Untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Husref Tahirovic; Alma Toromanovic; Marina Grubic; Zorana Grubic; Katja Dumic
Journal:  Eur J Pediatr       Date:  2008-10-16       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.